CN111549029A - Duck Mx promoter mutant and construction method and application of recombinant plasmid of luciferase reporter gene thereof - Google Patents

Duck Mx promoter mutant and construction method and application of recombinant plasmid of luciferase reporter gene thereof Download PDF

Info

Publication number
CN111549029A
CN111549029A CN202010447949.1A CN202010447949A CN111549029A CN 111549029 A CN111549029 A CN 111549029A CN 202010447949 A CN202010447949 A CN 202010447949A CN 111549029 A CN111549029 A CN 111549029A
Authority
CN
China
Prior art keywords
dumxp
duck
mut
primer
amplification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010447949.1A
Other languages
Chinese (zh)
Inventor
李国勤
卢立志
顾天天
田勇
陈黎
曾涛
沈军达
陶争荣
徐坚
杜雪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Academy of Agricultural Sciences
Original Assignee
Zhejiang Academy of Agricultural Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Academy of Agricultural Sciences filed Critical Zhejiang Academy of Agricultural Sciences
Priority to CN202010447949.1A priority Critical patent/CN111549029A/en
Publication of CN111549029A publication Critical patent/CN111549029A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a method for constructing duck Mx promoter mutants and luciferase reporter gene recombinant plasmids thereof and application thereof, wherein the method comprises the following steps of 1, PCR amplification and recovery of duck TLR7 gene; step 2In Fusion carries out recombination of the vector and the target fragment. Through a gene mutation technology, the ISRE1 sequence AGTTTCGTTTCT on duck Mx gene promoter duMxp on NCBI is subjected to site-directed mutagenesis AGGGTCGGGTCT, and the Mx gene promoter containing ISRE1 mutant is successfully cloned; and the In Fusion seamless cloning method is adopted to insert the In Fusion seamless cloning method into luciferase reporter genes pGL3-Basic Kpn/XhoI, so that a luciferase reporter system containing the Mx gene promoter sequence of the ISRE1 mutant is successfully constructed, and a foundation is laid for further researching the expression regulation mechanism of duck Mx genes and discussing targeted gene therapy.

Description

Duck Mx promoter mutant and construction method and application of recombinant plasmid of luciferase reporter gene thereof
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a duck Mx promoter mutant and a construction method and application of a luciferase reporter gene recombinant plasmid thereof.
Background
Interferon (Interferon, IFN) is an important antiviral active substance, is an important component of the non-specific immune system of the body, and has wide application in anti-infection and tumor clinical treatment of animals and humans. INF is classified into three types: type I IFN-alpha and IFN-beta, wherein IFN-alpha has more than twenty subtypes and IFN-beta has only one subtype. The type I interferon has the effects of inhibiting virus replication, resisting parasites, inhibiting proliferation of various cells, stimulating killing activity of immune cells, participating in immune regulation, resisting tumors and the like; type II only contains IFN-gamma, and only has a subtype, and besides the antiviral and antiproliferative activity, the main biological activity is the immunoregulation function; type III includes IFN-. lambda.1 (IL-29), IFN-. lambda.2 (IL-28a) and IFN-. lambda. (IL-28 b). Research has shown that the major pathway for type i IFNs to exert their antiviral biological functions is via the JAK-STAT signal transduction pathway, i.e. IFN- α/β first acts on type i IFN receptors, activating JAK1 and TYK2, causing tyrosine phosphorylation of STAT proteins, and forming STAT1-STAT2-IRF9 complex, i.e. IFN-stimulated gene factor 3 (ISGF 3), which translocates ISGF3 into the nucleus, binding to the antiviral protein gene promoter containing IFN-stimulated response element (ISRE), resulting in the expression of a series of IFN-induced antiviral protein genes, producing various antiviral proteins, such as protein kinase, 2 ', 5' -oligoadenylate synthetase, Mx protein, etc. Among them, Mx protein is considered as the most specific IFN action index, which can directly inhibit virus replication. Thus, the Mx protein (containing the promoter ISRE) is critical for the biological function of type I IFN.
A promoter is a DNA sequence located upstream of the 5' end of a structural gene, which activates RNA polymerase to bind to a template DNA precisely and with transcription initiation specificity, and contains a conserved sequence required for RNA polymerase specific binding and transcription initiation. The promoter itself is not transcribed, it behaves like a "switch", determining the activity of the gene. However, the promoter itself does not directly control gene activity, but controls gene activity by binding to such a protein called a transcription factor. Transcription factors, like "flags," direct the action of RNA polymerase, which makes RNA copies of a gene. The promoters can be classified into the following three types according to their functions and transcription patterns: inducible promoters, constitutive promoters, and tissue-specific promoters. Promoters contain a core promoter region and regulatory regions. The structure of the promoter affects its affinity for RNA polymerase, and thus the level of gene expression and the efficiency of transcription. Changes (mutations) in the promoter portion of the gene result in a failure to regulate gene expression. Thus, it can be seen that the promoter is an important cis-acting element for regulating the gene of interest. The structure and the regulation mechanism of the promoter are deeply researched, which is helpful for researching the expression characteristics and functions of the gene.
The Luciferase (Luciferase, luc) reporter gene system is a reporter system for detecting the activity of firefly Luciferase (firefly Luciferase) by using luciferin (Luciferase) as a substrate, can sensitively and efficiently detect the expression of genes, and is a detection method for detecting the interaction of transcription factors and target gene promoter region DNA. Among the existing reporter gene systems, the luc detection system is faster and more sensitive than other reporter gene detection systems such as Chloramphenicol Acetyltransferase (CAT), beta-galactosidase (Lac Z) and the like. The method only needs a few minutes to detect 96 samples by adopting the luc system, is convenient for large-flux detection, has the detection capacity as low as 10-20mol, is 100 times more sensitive than CAT, has extremely high sensitivity, is safe and has no radioactivity. The luc reporter gene assay system is widely used in studies on receptor activity, intracellular signaling, mRNA processing, protein folding, protein-protein interaction, and the like.
Disclosure of Invention
The invention aims to provide a duck Mx promoter mutant and a construction method and application of a luciferase reporter gene recombinant plasmid thereof. By means of gene mutation (overlap extension PCR) technology, the ISRE1 sequence (AGTTTCGTTTCT) on duck Mx gene promoter (duMxp) on NCBI is subjected to site-directed mutagenesis (AGGGTCGGGTCT), and the Mx gene promoter containing ISRE1 mutant is successfully cloned; and the In Fusion seamless cloning method is adopted to insert the In Fusion seamless cloning method into luciferase reporter gene pGL3-Basic (Kpn/XhoI), and a luciferase reporter system (pGL3-duMxp-ISRE1-Mut) containing the Mx gene promoter sequence of the ISRE1 mutant is successfully constructed, so that a foundation is laid for further researching the expression regulation mechanism of duck Mx genes and discussing targeted gene therapy.
The specific technical scheme is as follows:
the method for constructing the duck Mx promoter mutant and the luciferase reporter gene recombinant plasmid thereof comprises the following steps:
step 1, PCR amplification and recovery of duck Mx gene
1.1 form
Adopting duck plasmid as template;
1.2 design of primers
According to a duck Mx gene reference sequence (LOC101793492) given by NCBI, designing a PCR primer according to an overlapping extension PCR primer design principle, designing two complementary primers with variant gene bases at the position of an Mx promoter ISRE1 needing mutagenesis, and respectively designing an Mx promoter sequence 5 'primer and a Mx promoter sequence 3' primer;
1.3PCR amplification System and conditions
1.3.1PCR1 amplification System and conditions
In a 50. mu.L reaction system, sterilized deionized water, duMxp-Wild-F (10. mu.M), duMxp-ISRE 1-Mut-R (10uM), duck plasmid and
Figure BDA0002506633420000034
PCR Supermix, High Fidelity. The PCR1 amplification reaction system is as follows:
Figure BDA0002506633420000031
PCR1 amplification was performed under the following conditions
Figure BDA0002506633420000032
1.3.2PCR2 amplification System and conditions
In a 50. mu.L reaction system, sterilized deionized water, duMxp-ISRE 1-Mut-F (10. mu.M), duMxp-Wild-R (10. mu.M), duck plasmid and
Figure BDA0002506633420000035
PCR Supermix, High Fidelity, PCR2 amplification reaction system was as follows:
Figure BDA0002506633420000033
PCR2 amplification was performed according to the following conditions:
Figure BDA0002506633420000041
1.4 overlapping PCR amplification results
And performing overlapping PCR amplification by using the PCR1 amplification product and the PCR2 amplification product as a common template and using the DuMxp-Wild-F and the DuMxp-Wild-R as primers, wherein the amplification system and conditions are the same as 1.3. The obtained PCR product (DuMxp-ISRE1-Mut) was subjected to agarose gel electrophoresis, and the PCR amplification product was recovered by cutting gel, followed by the following fusion reaction.
Step 2, recombining the vector and the target fragment by In Fusion
By using
Figure BDA0002506633420000043
Seamless Cloning and Assembly Enzyme Mix (Invitrogen cat # A14606) was subjected to pGL3-duMxp-ISRE1-construction of recombinant plasmid for Mut reporter gene. The specific reaction system and conditions are as follows:
Figure BDA0002506633420000042
reaction conditions are as follows: standing at room temperature for 20 min; after 2-3min on ice, competent cells DH 5. alpha. were transformed in their entirety.
Further, the complementary primers in step 1 are primer duMxp-ISRE 1-Mut-R and primer duMxp-ISRE 1-Mut-F, and the nucleotide sequences thereof are shown in SEQ ID NO: 1-SEQ ID NO: 2, the 5 'primer and the 3' primer of the Mx promoter sequence are a primer duMxp-Wild-F and a primer duMxp-Wild-R, and the nucleotide sequences are shown in SEQ ID NO: 3-SEQ ID NO: 4, respectively.
Further, a positive single colony is selected for sequencing, and the constructed pGL3-duMxp-ISRE1-Mut reporter gene recombinant plasmid has a sequencing result shown in SEQ ID NO: 5, respectively.
The method is applied to the preparation process of the reagent for detecting the biological activity and the regulation mechanism of duck type I interferon.
The method of the invention is applied to the preparation process of the reagent for detecting the biological activity of the type I IFN of the mammal.
Still further, the mammal is a cow, a pig, a human, or the like.
Compared with the prior art, the invention has the beneficial effects that:
(1) the invention clones duck Mxp promoter (DuMxp-ISRE1-Mut) containing IFN stimulating response element (ISRE1) mutant, establishes an IFN biological activity detection system based on DuMxp-ISRE1-Mut luciferase reporter gene recombinant plasmid (pGL3-DuMxp-ISRE1-Mut), and can be used for detecting the biological activity and regulation mechanism of duck I-type interferon.
(2) The sequence of ISRE1 in the Mx promoter sequence of duck (5'-AGT T TCG TT TCT-3') is consistent with that of ISRE gene sequence of Mx promoter of mammal (5 '-A/GG TT TCN (1-2) T TTCC/T-3'). Therefore, the IFN biological activity detection system established by the invention not only can be used for detecting the biological activity and the regulation and control mechanism of duck type I interferon, but also can be used for detecting the type I IFN biological activity of mammals such as cows, pigs, people and the like, has wide applicability, and is an important tool for IFN related basic research and application research.
(3) The luciferase reporter gene recombinant plasmid (pGL3-duMxp-ISRE1-Mut) constructed by the invention not only can be used for detecting the influence of different stimulating factors such as IFN and the like on Mx gene expression in immune cells, but also can be used as a platform for screening antiviral infection drugs taking Mx as a target gene, and is a potential target for researching and screening anti-infective drugs.
(4) The invention adopts an In Fusion seamless cloning method to recombine the vector and the target fragment, is not limited by the traditional cloning method, can keep excellent accuracy for various cloning applications no matter the type of the vector or the composition of the inserted fragment, and does not need the subcloning operation of the traditional connection method. Even if the size of the inserted fragment or the number of fragments is increased, the cloning success rate is still high and is faster than that of the traditional ligase method.
(5) The invention adopts for constructing recombinant plasmid
Figure BDA0002506633420000051
The Seamless Cloning and analysis Enzyme Mix Seamless Enzyme mixing technology can be used for creating a construct with the length of up to 13kb and can be used for high-throughput assembly, 1 to 4 random sequences can be combined into a PCR fragment in a room-temperature reaction and can be cloned to any linear vector simultaneously and directionally, and the advantages of ① rapidness, 15-minute reaction time, ② simplicity, no influence of fragment digestion sites and no need of fragment digestion, ③ high efficiency, more than 95 percent of positive rate, ④ Seamless property, no introduction of additional sequences and the like are achieved.
Drawings
FIG. 1 is a diagram showing the results of agarose gel electrophoresis of PCR products, wherein M: DL5K DNA marker (100, 250, 500, 750, 1000, 2000, 3000, 5000bp), 1: DuMxp-ISRE1-Mut CDS PCR amplification product (2039 bp);
FIG. 2 is the effect of duck RIG-I overexpression on Mx gene expression;
FIG. 3 is the effect of duck RIG-I interference on Mx gene expression.
Detailed Description
The technical solution of the present invention will be described in further detail with reference to the accompanying drawings and specific embodiments.
PCR amplification and recovery of Mx gene of 1 duck
1.1 form
Duck plasmid is adopted as a template.
1.2 design of primers
According to a duck Mx gene reference sequence (LOC101793492) given by NCBI, PCR primers are designed according to an overlap extension PCR primer design principle, two complementary primers (a primer duMxp-ISRE 1-Mut-R and a primer duMxp-ISRE 1-Mut-F) with variant gene bases are designed at the position of an Mx promoter ISRE1 needing mutagenesis, and an Mx promoter sequence 5 'primer and a 3' primer (a primer duMxp-Wild-F and a primer duMxp-Wild-R) are respectively designed (Table 1).
TABLE 1 primer names and sequences
Figure BDA0002506633420000061
1.3PCR amplification System and conditions
1.3.1PCR1 amplification System and conditions
As shown in Table 2, in a 50. mu.L reaction system, sterilized deionized water, DuMxp-Wild-F (10. mu.M), DuMxp-ISRE 1-Mut-R (10. mu.M), duck plasmid and
Figure BDA0002506633420000063
PCR SuperMix,High Fidelity。
TABLE 2PCR amplification reaction System
Figure BDA0002506633420000062
Figure BDA0002506633420000071
Injecting: invitrogen, cat no: 12532-016
PCR1 amplification was performed according to the conditions shown in Table 3.
TABLE 3PCR 1 amplification reaction conditions
Figure BDA0002506633420000072
1.3.2PCR2 amplification System and conditions
As shown in Table 4, in a 50. mu.L reaction system, sterilized deionized water, DuMxp-ISRE 1-Mut-F (10. mu.M), DuMxp-Wild-R (10. mu.M), duck plasmid and
Figure BDA0002506633420000074
PCR SuperMix,High Fidelity。
TABLE 4 PCR2 amplification reaction System
Figure BDA0002506633420000073
Injecting: invitrogen, cat no: 12532-016
PCR2 amplification was performed according to the conditions shown in Table 5.
TABLE 5 PCR2 amplification reaction conditions
Figure BDA0002506633420000081
1.4 overlapping PCR amplification results
And performing overlapping PCR amplification by using the PCR1 amplification product and the PCR2 amplification product as a common template and using the DuMxp-Wild-F and the DuMxp-Wild-R as primers, wherein the amplification system and conditions are the same as 1.3. The PCR product (duMxp-ISRE1-Mut) was subjected to agarose gel electrophoresis, and the results are shown in FIG. 1.
The PCR amplification product was recovered by cutting gel, and the following fusion reaction was carried out.
2In Fusion for recombination of vector and target fragment
By using
Figure BDA0002506633420000083
Seamless Cloning and Assembly Enzyme Mix (Invitrogen Cat.: A14606) for pGL3-duMxp-ISRE1-Mut reporter gene recombinationAnd (5) constructing a plasmid. The specific reaction system and conditions are as follows:
TABLE 6 DuMxp-ISRE1-Mut and pGL3-Basic fusion reaction systems and conditions
Figure BDA0002506633420000082
3 analysis of sequencing results
And selecting positive single colonies for sequencing, wherein the constructed pGL3-duMxp-ISRE1-Mut reporter gene recombinant plasmid sequencing result (2039bp) is shown as SEQ ID NO: 5, respectively.
Example 1 Duck RIG-I Gene Regulation of Mx Gene expression in Duck Embryo Fibroblasts (DEFs) study 1 construction of Duck RIG-I overexpression vector plasmid
The duck RIG-I (dRIG-I) gene Open Reading Frame (ORF) is inserted into a pcDNA3.1+ -HA vector by adopting a Clonexpress II One Step Cloning Kit, a pcDNA3.1+ -HA-dRIG-I plasmid is constructed, and a DNA sequencing method is applied for identification.
2 transfection reaction
DEFs were cultured until the fusion degree reached 70% -90%, 2. mu.g/well duck RIG-I overexpression vector plasmid (pcDNA3.1+ -HA-dRIG-I), siRNA (sequences GCAAACCUCCACCUGUCUATT and UAGACAGGUGGAGGUUUGCTT) and blank vector were transfected into DEFs using Lipofectamine 2000(Invitrogen) reagent, respectively, and after 24h transfection, the expression level of Mx gene in DEFs by duck RIG-I gene pair was determined by stimulating DEF (I: C) (500 ng/well).
PCR amplification and recovery of Mx gene of 3 ducks
3.1 form
Duck plasmid is adopted as a template.
3.2 design of primers
According to a duck Mx gene reference sequence (LOC101793492) given by NCBI, PCR primers are designed according to an overlap extension PCR primer design principle, two complementary primers (a primer duMxp-ISRE 1-Mut-R and a primer duMxp-ISRE 1-Mut-F) with variant gene bases are designed at the position of an Mx promoter ISRE1 needing mutagenesis, and an Mx promoter sequence 5 'primer and a 3' primer (a primer duMxp-Wild-F and a primer duMxp-Wild-R) are respectively designed (Table 1).
3.3PCR amplification System and conditions
3.3.1PCR1 amplification System and conditions
As shown in Table 2, in a 50. mu.L reaction system, sterilized deionized water, DuMxp-Wild-F (10. mu.M), DuMxp-ISRE 1-Mut-R (10. mu.M), duck plasmid and
Figure BDA0002506633420000091
PCR SuperMix,High Fidelity。
PCR1 amplification was performed according to the conditions shown in Table 3.
3.3.2PCR2 amplification System and conditions
As shown in Table 4, in a 50. mu.L reaction system, sterilized deionized water, DuMxp-ISRE 1-Mut-F (10. mu.M), DuMxp-Wild-R (10. mu.M), duck plasmid and
Figure BDA0002506633420000092
PCR SuperMix,High Fidelity。
PCR2 amplification was performed according to the conditions shown in Table 5.
3.4 overlapping PCR amplification results
And performing overlapping PCR amplification by using the PCR1 amplification product and the PCR2 amplification product as a common template and using the DuMxp-Wild-F and the DuMxp-Wild-R as primers, wherein the amplification system and conditions are the same as 1.3. The PCR product (duMxp-ISRE1-Mut) was subjected to agarose gel electrophoresis, and the results are shown in FIG. 1.
The PCR amplification product was recovered by cutting gel, and the following fusion reaction was carried out.
4In Fusion for recombination of vector and target fragment
By using
Figure BDA0002506633420000093
A recombinant plasmid pGL 3-dummxp-ISRE 1-Mut reporter gene was constructed by Seamless Cloning and Assembly Enzyme Mix (Invitrogen cat # A14606). Specific reaction systems and conditions are shown in table 6.
5 analysis of sequencing results
And selecting positive single colonies for sequencing, wherein the constructed pGL3-duMxp-ISRE1-Mut reporter gene recombinant plasmid sequencing result (2039bp) is shown as SEQ ID NO: 5, respectively.
6qRT-PCR (quantitative reverse transcription-polymerase chain reaction) for detecting Mx gene expression level of duck in DEFs (defecas)
Primers (qMx-F, AAGACGGTGGGAAGGAG; qMx-R, AGTTGTCGCCGAAGTCA) were designed based on the sequence of SEQ ID NO. 5, and 20. mu.l PCR amplification reaction system was used, including SYBR Green Master Mix 10. mu.l, qMx-F0.4. mu.l, qMx-R0.4. mu.l, cDNA template 2. mu.l, and sterilized deionized water 7.2. mu.l, PCR2 amplification was performed according to the following conditions, including pre-denaturation (95 ℃, 30sec), 40 cycles (95 ℃, 10 sec; 60 ℃, 30sec), duck β -actin as internal reference, relative expression level was 2-ΔΔCtThe method calculates, and the result is shown in fig. 2 and fig. 3.
The above description is only a preferred embodiment of the present invention, and the scope of the present invention is not limited thereto, and any simple modifications or equivalent substitutions of the technical solutions that can be obviously obtained by those skilled in the art within the technical scope of the present invention are within the scope of the present invention.
Sequence listing
<110> Zhejiang province academy of agricultural sciences
<120> duck Mx promoter mutant and construction method and application of luciferase reporter gene recombinant plasmid thereof
<160>5
<170>SIPOSequenceListing 1.0
<210>1
<211>37
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>1
ttctctatcg ataggtacca cctcagcagg gaagcac 37
<210>2
<211>28
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>2
attgctgagg ccagacccga ccctccat 28
<210>3
<211>28
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>3
atggagggtc gggtctggcc tcagcaat 28
<210>4
<211>45
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>4
cttagatcgc agatctcgag agacacagta actgttctca attgc 45
<210>5
<211>2039
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>5
ttctctatcg ataggtacca cctcagcagg gaagcaccac ctccctcagc tgccagggct 60
ggttctacct gcattaggga tgcagtgaaa ttgaggaaat ggaggctccc tctctgctca 120
gcagagggta ggagaaacct ggagaagcag agatgatgtg cttcaccctc tagtctcttc 180
tgggcattgc agcatgatga agtggagcca tctcctctct caaaacaagg ttacagaagt 240
gtctgccctt tctcttccag gacatgtgcc ttgaccagca gctctaccct ctgttaacag 300
cctcctgcct ggatgggacc taagtccccc atggtgggca tcacagcaag atgatttgcc 360
agcaaatggt tcatatttag caggtacagt gacatagctg ttctcttcac ttgcttttcc 420
tacagctgct gctcacaggc ttaaatattg tgtgattcaa caaggatcaa tgcatactct 480
tacagtatgt cccatttttt tcttcatcaa aattatttcc aaacatactc tgtacagctg 540
agatttgaat gaaattcagt ttaatctatt tttatacatc ctttattgtg ttgtcttaat 600
ccgtagaatt gtactgccag taggacatgc tggtataagt cattacataa agatgaaacc 660
tgttttcaat gcattatttc ccagtgggtt ttccagtgtg ttaaagatgt tattatgctg 720
attcaggaga aaataggaga acctaaatct ctacaatggg agaaaggaga accctgtcct 780
gttcctgcag agcaagctgc agaatccttc tggtgctgct cagagctcct ctctgaaaca 840
tgcagaggat tgaacaaaac cctttaacca agacaacccc atcggcaatg ctcaaaatta 900
ataacccagt tggtgtatgt gggaacttat tcccttgcag gtctgtctcc tacgtgcctg 960
agggtatgat gaccagtgcc agagggaggc caggacctgc tgcagcccta atagtggtga 1020
cccgggggtg gcatcgggtg ggacagggag ggaggaagat gggctggctc tgaaactgca 1080
acatgccgtt tctggtcagt ctaatctgca ggggaaagtt gggcaatttg agaatcactc 1140
aaaaaaaaaa aaaaatggaa tcgagagtgg ctgataaagg cagcagtcag aaacagagga 1200
actgctaaat aacagagaaa gctgattttg cctaacagct cagaacgcat aaaacaccaa 1260
aaatgggagc aggagagtga cgacagccaa tgactctgag aaacagtgcg gaaacactgg 1320
agacttcacc tgccctgcac tggtgcgcag ccctgagaag tgcctggcag cagcgcaggg 1380
cagcaatggc tcagccctgc cagtatggcc aggttggagg ggcaggcatg gagatgccaa 1440
aagcacacac acacacacac acacaagcct cctgccactt gtacaaattg gggtgctggg 1500
cagcagcaag acatcaattt ctttgatttt ttccctatcc tggtaaacaa tatattcctc 1560
cccgatcctt ttctttacac actagccaac tctcttcctg atatttagca gacagcagaa 1620
acaaaactcc ctgttttccg ctgcagtggg accagagggc aaatggcaga ggtgccaggc 1680
aatattgttg gtgagcgaca gaggtgcaga gtggccactt tggtgagcca gcctattagg 1740
gggagataag gagctgttgc ttgccagcac cccattttgc acattttagg tcctgctgca 1800
gggggaaatc acaggatgag gatggagggt cgggtctggc ctcagcaatg caccaggaag 1860
aaaggtggtt ctggtataaa aaggaaaaag acatcacgtt cctatttcca aagctgttaa 1920
ttgggagcag tttcatttct cccaattctt gtcacagtgt gtaggtggag cctgtacata 1980
aaaaagcacc caaagcaatt gagaacagtt actgtgtctc tcgagatctg cgatctaag 2039

Claims (6)

1. The method for constructing the duck Mx promoter mutant and the luciferase reporter gene recombinant plasmid thereof is characterized by comprising the following steps of:
step 1, PCR amplification and recovery of duck TLR7 gene
1.1 form
Adopting duck plasmid as template;
1.2 design of primers
According to a duck Mx gene reference sequence LOC101793492 given by NCBI, designing a PCR primer according to an overlapping extension PCR primer design principle, designing two complementary primers with variant gene bases at the position of an Mx promoter ISRE1 needing mutagenesis, and respectively designing an Mx promoter sequence 5 'primer and a Mx promoter sequence 3' primer;
1.3PCR amplification System and conditions
1.3.1PCR1 amplification System and conditions
In a 50 mu L reaction system, respectively adding sterilized deionized water, 10 mu M duMxp-Wild-F, 10 mu M duMxp-ISRE 1-Mut-R, duck plasmid and
Figure FDA0002506633410000011
PCR Supermix, High Fidelity; the 50. mu.l PCR amplification reaction was used as follows: sterilized deionized water 1.0. mu.l, duMxp-Wild-F1.0. mu.l with a concentration of 10. mu.M, duMxp-ISRE 1-Mut-R1.0. mu.l with a concentration of 10. mu.M, duck plasmid 2.0. mu.l,
Figure FDA0002506633410000012
PCR SuperMix,HighFidelity*45μl;
PCR1 amplification was performed as follows: pre-denaturation: 94 ℃, 2min, 32 cycles: 94 ℃, 30 sec; 60 ℃ for 30 sec; at 68 ℃ for 2 min;
1.3.2PCR2 amplification System and conditions
In a 50 mu L reaction system, respectively adding sterilized deionized water, 10 mu M duMxp-ISRE 1-Mut-F, 10 mu M duMxp-Wild-R, duck plasmid and
Figure FDA0002506633410000013
PCR Supermix, High Fidelity, using a 50. mu.l PCR2 amplification reaction system was as follows: sterilized deionized water 1.0. mu.l, duMxp-ISRE 1-Mut-F1.0. mu.l at a concentration of 10. mu.M, duMxp-Wild-R1.0. mu.l at a concentration of 10. mu.M, duck plasmid 2.0. mu.l,
Figure FDA0002506633410000014
PCR SuperMix,HighFidelity*45μl;
PCR2 amplification was performed according to the following conditions: pre-denaturation: 94 ℃, 2min, 32 cycles: 94 ℃, 30 sec; 60 ℃ for 30 sec; 68 ℃ for 30 sec;
1.4 overlapping PCR amplification results
Performing overlapping PCR amplification by using PCR1 amplification products and PCR2 amplification products as common templates and using DuMxp-Wild-F and DuMxp-Wild-R as primers; carrying out agarose gel electrophoresis on the obtained PCR product duMxp-ISRE1-Mut, cutting and recycling PCR amplification products, and carrying out the following fusion reaction;
step 2, recombining the vector and the target fragment by In Fusion
By using
Figure FDA0002506633410000021
Constructing pGL 3-dummxp-ISRE 1-Mut reporter gene recombinant plasmid by using Seamless Cloning and Assembly Enzyme Mix; the specific reaction system and conditions are as follows: sterilized deionized water 2.0. mu.l, purified product of DuMxp-ISRE1-Mut 2.0. mu.l, pGL3-Basic 1.0. mu.l,
Figure FDA0002506633410000022
2X Enzyme Mix 5.0. mu.l, total 10. mu.l;
reaction conditions are as follows: standing at room temperature for 20 min; after 2-3min on ice, competent cells DH 5. alpha. were transformed in their entirety.
2. The method for constructing the duck Mx promoter mutant and the luciferase reporter gene recombinant plasmid thereof according to claim 1, wherein the complementary primers in the step 1 are primer duMxp-ISRE 1-Mut-R and primer duMxp-ISRE 1-Mut-F, and the nucleotide sequence of the complementary primers is shown in SEQ ID NO: 1-SEQ ID NO: 2, the 5 'primer and the 3' primer of the Mx promoter sequence are a primer duMxp-Wild-F and a primer duMxp-Wild-R, and the nucleotide sequences are shown in SEQ ID NO: 3-SEQ ID NO: 4, respectively.
3. The method for constructing the duck Mx promoter mutant and the luciferase reporter gene recombinant plasmid thereof according to claim 1, wherein a positive single colony is selected for sequencing, and the sequencing result of the constructed pGL3-duMxp-ISRE1-Mut reporter gene recombinant plasmid is shown as SEQ ID NO: 5, respectively.
4. Use of the method of claim 1 in the preparation of reagents for detecting the biological activity and regulatory mechanisms of duck type i interferon.
5. Use of the method of claim 1 in the preparation of a reagent for the detection of the biological activity of type I IFN in a mammal.
6. The use of claim 5, wherein the mammal is a bovine, porcine, human.
CN202010447949.1A 2020-05-25 2020-05-25 Duck Mx promoter mutant and construction method and application of recombinant plasmid of luciferase reporter gene thereof Pending CN111549029A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010447949.1A CN111549029A (en) 2020-05-25 2020-05-25 Duck Mx promoter mutant and construction method and application of recombinant plasmid of luciferase reporter gene thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010447949.1A CN111549029A (en) 2020-05-25 2020-05-25 Duck Mx promoter mutant and construction method and application of recombinant plasmid of luciferase reporter gene thereof

Publications (1)

Publication Number Publication Date
CN111549029A true CN111549029A (en) 2020-08-18

Family

ID=72001063

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010447949.1A Pending CN111549029A (en) 2020-05-25 2020-05-25 Duck Mx promoter mutant and construction method and application of recombinant plasmid of luciferase reporter gene thereof

Country Status (1)

Country Link
CN (1) CN111549029A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101603076A (en) * 2008-06-11 2009-12-16 中国农业科学院哈尔滨兽医研究所 Detect the clone and the application thereof of I type interferon biological activity
CN107841530A (en) * 2017-12-05 2018-03-27 安徽九川生物科技有限公司 Chemical-activated luciferase gene expression chicken interferon α biological activity detection methods
CN110872597A (en) * 2019-11-22 2020-03-10 浙江省农业科学院 Construction and identification method of duck TLR7 eukaryotic expression recombinant plasmid vector

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101603076A (en) * 2008-06-11 2009-12-16 中国农业科学院哈尔滨兽医研究所 Detect the clone and the application thereof of I type interferon biological activity
CN107841530A (en) * 2017-12-05 2018-03-27 安徽九川生物科技有限公司 Chemical-activated luciferase gene expression chicken interferon α biological activity detection methods
CN110872597A (en) * 2019-11-22 2020-03-10 浙江省农业科学院 Construction and identification method of duck TLR7 eukaryotic expression recombinant plasmid vector

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GENBANK: "Genbank:NC_040046.1", 《GENBANK》 *
TIANTIAN GU ET AL.: "Molecular cloning, expression and mimicking antiviral activity analysis of retinoic acid-inducible gene-I in duck (Anas platyrhynchos)", 《JOURNAL OF GENETICS》 *

Similar Documents

Publication Publication Date Title
Rohde et al. Characterization of chicken tumor necrosis factor-α, a long missed cytokine in birds
Davis et al. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation
McCormack et al. Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2α protein kinase
Stark et al. The JAK-STAT pathway at twenty
Veals et al. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins
LaFleur et al. Interferon-κ, a novel type I interferon expressed in human keratinocytes
Morandi et al. Multiple forms of human dihydrofolate reductase messenger RNA: cloning and expression in Escherichia coli of their DNA coding sequence
US20200292546A1 (en) A NOVEL INTERFERON-(lambda)4 (IFNL-4) PROTEIN, RELATED NUCLEIC ACID MOLECULES, AND USES THEREOF
Zhu et al. Fudenine, a C-terminal truncated rat homologue of mouse prominin, is blood glucose-regulated and can up-regulate the expression of GAPDH
Lieber et al. High level gene expression in mammalian cells by a nuclear T7-phage RNA polymerase
CN114107496B (en) Application of reagent for detecting RIG-I-Short expression level in preparation of tumor diagnosis and/or prognosis products
Floyd-Smith et al. Transcriptional induction of the p69 isoform of 2′, 5′-oligoadenylate synthetase by interferon-β and interferon-γ involves three regulatory elements and interferon-stimulated gene factor 3
Furnes et al. Molecular cloning and characterization of bloodthirsty from Atlantic cod (Gadus morhua)
CN111549029A (en) Duck Mx promoter mutant and construction method and application of recombinant plasmid of luciferase reporter gene thereof
CN110669765B (en) Mandarin interferon inducible protein promoter and application
Yang et al. Functional analysis of a dominant negative mutation of interferon regulatory factor 5
Larner et al. Interferon signal transduction
Wen et al. Cloning, characterization and expression analysis of two Tetraodon nigroviridis interleukin-16 isoform genes
CN104818281B (en) One boar Lgr5 genes and its application
Lou et al. Molecular cloning and characterization of rat chemokine-like factor 1 and 2
Holland et al. A type I interferon signaling factor, ISF21, encoded on chromosome 21 is distinct from receptor components and their down-regulation and is necessary for transcriptional activation of interferon-regulated genes
DENT et al. Relative transcriptional inducibility of the human interferon-α subtypes conferred by the virus-responsive enhancer sequence
Mayumi et al. Improved restriction landmark cDNA scanning and its application to global analysis of genes regulated by nerve growth factor in PC12 cells
Xue et al. ZNF300, a recently identified human transcription factor, activates the human IL-2Rβ promoter through the overlapping ZNF300/EGR1 binding site
CN110054680A (en) One boar, III type interferon receptors IFNLR1 * subunit recombinant protein and its application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200818